human | Q5 |
P6104 | maintained by WikiProject | WikiProject Invasion Biology | Q56241615 |
P106 | occupation | author | Q482980 |
Q61845229 | 14: Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes |
Q61845231 | 171: The frequency and clinical significance of intra-amniotic infection in women with placenta previa and vaginal bleeding: an unexpected observation |
Q61845234 | 1: Identification of signature pathways at the site of rupture in chorionic membranes in spontaneous labor at term |
Q61845237 | 227: Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term |
Q61845239 | 272: Retinol-binding protein-4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus |
Q61845244 | 325: The molecular signature of an arrest of descent in human parturition |
Q57081283 | 497: Fetal death: an extreme form of maternal anti-fetal rejection |
Q61845256 | 520: Activation of the alternative pathway of complement is a feature of preterm parturition but not of spontaneous labor at term |
Q61845258 | 521: One of every four patients with an asymptomatic short cervix (15mm) has subclinical intra-amniotic inflammation: implications for patient counseling and management |
Q61845262 | 528: A role for placental alpha-microglobulin-1 in the identification of women with a sonographic short cervix at risk for spontaneous rupture of membranes |
Q61845265 | 534: Evidence in support for a role of anti-angiogenic factors in preterm prelabor rupture of membranes (PPROM) |
Q61845267 | 535: A molecular investigation of the microbial diversity and burden in preterm PROM reveals a high rate of infection with a broad range of organisms including gastrointestinal tract microbiota |
Q57081284 | 599: A receptor for danger signals, advanced glycation end products (RAGE) in fetal systemic inflammation and clinical chorioamnionitis |
Q44885078 | 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase form a supramolecular complex in human neutrophils that undergoes retrograde trafficking during pregnancy |
Q57081293 | 650: sTRAIL, a prognostic marker for future death from cardiovascular disease, is decreased in maternal plasma of patients with preeclampsia |
Q61845269 | 653: Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with pyelonephritis |
Q57081296 | 657: Third trimester neutrophil gelatinase-associated lipocalin and angiogenic/anti-angiogenic factors for the identification of late preeclampsia |
Q61845092 | 658: Diagnostic performance of leptin and total adiponectin determined in the third trimester for the identification of late preeclampsia compared to angiogenic/anti-angiogenic and clinical factors |
Q61845272 | 692: Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small for gestational age |
Q61845274 | 73: Evidence for intersection between the angiogenic and inflammatory pathways in preterm labor and preterm PROM |
Q57081297 | 741: Changes in the cytokine TRAIL during pregnancy: a potential explanation for the susceptibility of pregnant women to the effects of infection |
Q61845276 | 791: Fetal death is associated with increased concentration of anti-angiogenic factors |
Q61845279 | 792: Fetal death: a condition with a disparity in SVEGFR-2 between the maternal and fetal compartments |
Q61845287 | 805: Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice |
Q61845096 | 823: Soluble α-klotho, an anti-aging protein, is reduced in patients with intra-amniotic infection |
Q41745449 | A "multi-hit" model of neonatal white matter injury: cumulative contributions of chronic placental inflammation, acute fetal inflammation and postnatal inflammatory events |
Q40866852 | A Role for the Inflammasome in Spontaneous Labor at Term |
Q40079838 | A Role for the Inflammasome in Spontaneous Labor at Term with Acute Histologic Chorioamnionitis |
Q40071832 | A Role for the Inflammasome in Spontaneous Preterm Labor With Acute Histologic Chorioamnionitis |
Q34119248 | A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix |
Q36221448 | A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia |
Q52546304 | A diagnostic approach for the evaluation of spina bifida by three-dimensional ultrasonography. |
Q34340129 | A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). |
Q33921037 | A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor |
Q36984261 | A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma |
Q40869335 | A longitudinal study of placental perfusion using dynamic contrast enhanced magnetic resonance imaging in murine pregnancy |
Q34645135 | A molecular signature of an arrest of descent in human parturition |
Q37637664 | A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes |
Q41439373 | A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection |
Q37623851 | A point of care test for the determination of amniotic fluid interleukin-6 and the chemokine CXCL-10/IP-10 |
Q36189562 | A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia |
Q61845292 | A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia |
Q36647322 | A rapid interleukin-6 bedside test for the identification of intra-amniotic inflammation in preterm labor with intact membranes |
Q58778355 | A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection |
Q58778278 | A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne's syndrome) |
Q39709543 | A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity |
Q33822254 | A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d |
Q36221487 | A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study |
Q36714154 | Activation of the alternative pathway of complement is a feature of pre-term parturition but not of spontaneous labor at term |
Q53639289 | Activation of villous trophoblastic p38 and ERK1/2 signaling pathways in preterm preeclampsia and HELLP syndrome. |
Q61845294 | Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma |
Q36317153 | Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma |
Q61845296 | Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: A novel association with intra-amniotic infection/inflammation |
Q36576826 | Adiponectin in amniotic fluid in normal pregnancy, spontaneous labor at term, and preterm labor: a novel association with intra-amniotic infection/inflammation |
Q36421349 | Amniotic fluid angiopoietin-2 in term and preterm parturition, and intra-amniotic infection/inflammation |
Q36977780 | Amniotic fluid concentration of surfactant proteins in intra-amniotic infection |
Q35186751 | Amniotic fluid fetal hemoglobin in normal pregnancies and pregnancies complicated with preterm labor or prelabor rupture of membranes |
Q36839897 | Amniotic fluid heat shock protein 70 concentration in histologic chorioamnionitis, term and preterm parturition |
Q34505066 | Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation |
Q61845298 | Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation |
Q36179791 | Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation |
Q61845301 | Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation |
Q34553502 | An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloimmunization: implications for the understanding of the fetal inflammatory response syndrome |
Q34505090 | An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study |
Q34653208 | Anaphylatoxins in preterm and term labor |
Q42248027 | Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage? |
Q35851208 | Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth |
Q36060590 | Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome |
Q33845963 | CXCL10 and IL-6: Markers of two different forms of intra-amniotic inflammation in preterm labor |
Q36676660 | CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? |
Q58778341 | Can heparin prevent adverse pregnancy outcome? |
Q46340423 | Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes |
Q34281817 | Cervical strain determined by ultrasound elastography and its association with spontaneous preterm delivery |
Q58778300 | Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes |
Q36487783 | Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation |
Q37612423 | Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome |
Q33729663 | Characteristic Changes in Decidual Gene Expression Signature in Spontaneous Term Parturition |
Q35861003 | Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue |
Q37612440 | Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response |
Q34989601 | Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term |
Q34281841 | Characterization of the myometrial transcriptome in women with an arrest of dilatation during labor |
Q36706662 | Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term |
Q55326781 | Characterization of visceral and subcutaneous adipose tissue transcriptome in pregnant women with and without spontaneous labor at term: implication of alternative splicing in the metabolic adaptations of adipose tissue to parturition. |
Q34822483 | Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome |
Q41462724 | Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniques |
Q41261983 | Clinical chorioamnionitis at term II: the intra-amniotic inflammatory response |
Q40158435 | Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection? |
Q40140125 | Clinical chorioamnionitis at term IV: the maternal plasma cytokine profile |
Q40139863 | Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response |
Q41008958 | Clinical chorioamnionitis at term VI: acute chorioamnionitis and funisitis according to the presence or absence of microorganisms and inflammation in the amniotic cavity |
Q37556492 | Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE |
Q33617367 | Correction: The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women |
Q36560160 | Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA? |
Q36165681 | Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1 |
Q34133012 | Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery |
Q34182374 | Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa |
Q61845303 | Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes |
Q36578019 | Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes |
Q40512735 | Divergent trophoblast responses to bacterial products mediated by TLRs |
Q36692476 | Dysregulation of maternal serum adiponectin in preterm labor |
Q30403903 | Effect of depth on shear-wave elastography estimated in the internal and external cervical os during pregnancy |
Q34356117 | Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor |
Q35547367 | Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes |
Q34119241 | Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia |
Q34263178 | Evaluation of utero-placental and fetal hemodynamic parameters throughout gestation in pregnant mice using high-frequency ultrasound |
Q36221493 | Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection |
Q61845306 | Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection |
Q36179324 | Evidence for differential regulation of the adipokine visfatin in the maternal and fetal compartments in normal spontaneous labor at term |
Q48578448 | Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis |
Q35015402 | Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes |
Q37612429 | Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death |
Q36677529 | Evidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome |
Q58417742 | Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death |
Q36372845 | Evidence of perturbations of the cytokine network in preterm labor |
Q35186914 | Evidence of the involvement of caspase-1 under physiologic and pathologic cellular stress during human pregnancy: a link between the inflammasome and parturition |
Q48348609 | Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award |
Q42452032 | Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes |
Q58778333 | Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes |
Q61845467 | Fetal and Maternal Responses to Intrauterine Infection |
Q30466036 | Fetal cardiac ventricular volume, cardiac output, and ejection fraction determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis |
Q36189578 | Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments |
Q40061417 | Fetal death: an extreme manifestation of maternal anti-fetal rejection |
Q43241362 | Fetal membranes as an interface between inflammation and metabolism: increased aquaporin 9 expression in the presence of spontaneous labor at term and chorioamnionitis |
Q38360811 | Fetal plasma MMP-9 concentrations are elevated in preterm premature rupture of the membranes |
Q36251428 | Four-dimensional fetal echocardiography with spatiotemporal image correlation (STIC): a systematic study of standard cardiac views assessed by different observers |
Q44718036 | Four-dimensional ultrasonography of the fetal heart with spatiotemporal image correlation |
Q36720470 | Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation |
Q34139940 | Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis |
Q35362708 | Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice |
Q57783970 | Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes |
Q54631058 | Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta. |
Q36369470 | Glycogen phosphorylase isoenzyme BB plasma concentration is elevated in pregnancy and preterm preeclampsia |
Q36050821 | Hematologic profile of the fetus with systemic inflammatory response syndrome |
Q54648888 | High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. |
Q36165666 | High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor |
Q35642361 | Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature |
Q57081257 | Human β-defensin-1: A natural antimicrobial peptide present in amniotic fluid that is increased in spontaneous preterm labor with intra-amniotic infection |
Q36185081 | Hyperresistinemia - a novel feature in systemic infection during human pregnancy |
Q42477131 | Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues |
Q35688704 | Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intraamniotic infection |
Q34114194 | Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes |
Q30816447 | Identification of novel functional sequence variants in the gene for peptidase inhibitor 3. |
Q61845541 | Idiopathic Fetal Death Is Associated with Evidence of Prior Antigenic Exposure |
Q51370548 | Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. |
Q34505704 | In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy |
Q34499499 | Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy |
Q33714774 | Increased protein-coding mutations in the mitochondrial genome of African American women with preeclampsia |
Q28210998 | Infection and prematurity and the role of preventive strategies |
Q34088174 | Infection and smoking are associated with decreased plasma concentration of the anti-aging protein, α-klotho |
Q58795465 | Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia |
Q36060670 | Interleukin-19 in fetal systemic inflammation |
Q34580869 | Intrauterine infection and prematurity |
Q34199341 | Intrauterine infection and the development of cerebral palsy |
Q36107337 | Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion |
Q36185268 | Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia |
Q40696194 | Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B4. |
Q36624466 | Longitudinal Changes in Placental Magnetic Resonance Imaging Relaxation Parameter in Murine Pregnancy: Compartmental Analysis |
Q33575629 | Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection |
Q34411185 | Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity |
Q35605144 | Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection |
Q36145631 | Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate |
Q58417749 | Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death |
Q34004087 | Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? |
Q52009983 | Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. |
Q41033848 | Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study |
Q36283981 | Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis |
Q36062460 | Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia |
Q33863973 | Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia |
Q34553772 | Maternal plasma retinol binding protein 4 in acute pyelonephritis during pregnancy |
Q33909572 | Maternal plasma soluble TRAIL is decreased in preeclampsia |
Q40367971 | Maternal plasma-soluble ST2 concentrations are elevated prior to the development of early and late onset preeclampsia - a longitudinal study |
Q36670594 | Maternal serum adiponectin multimers in gestational diabetes |
Q36675226 | Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn |
Q35194054 | Maternal serum adiponectin multimers in preeclampsia |
Q36512063 | Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies |
Q36569720 | Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis |
Q36406577 | Maternal visfatin concentration in normal pregnancy |
Q58778323 | Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity |
Q30524877 | Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery |
Q36342281 | Methylome of fetal and maternal monocytes and macrophages at the feto-maternal interface |
Q35886564 | Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods |
Q34234655 | Microbial invasion of the amniotic cavity in pregnancies with small-for-gestational-age fetuses |
Q35121220 | Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome |
Q36399892 | Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm deliver |
Q61845308 | Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection |
Q33660453 | Mitochondrial manganese superoxide dismutase mRNA expression in human chorioamniotic membranes and its association with labor, inflammation, and infection |
Q47765962 | Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection |
Q34499492 | Normal pregnancy is characterized by systemic activation of the complement system |
Q46877727 | Oxidant release is dramatically increased by elevated glucose concentrations in neutrophils from pregnant women |
Q34080320 | Patients with an asymptomatic short cervix ( |
Q34235212 | Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation |
Q36316857 | Pentraxin 3 in maternal circulation: an association with preterm labor and preterm PROM, but not with intra-amniotic infection/inflammation |
Q36355944 | Performance metrics after changes in screening protocol for congenital hypothyroidism |
Q57081304 | Placental Lesions Associated With Maternal Underperfusion Are More Frequent in Early-Onset Than in Late-Onset Preeclampsia |
Q34975562 | Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae |
Q35558666 | Placental lesions associated with acute atherosis |
Q35542826 | Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia |
Q34119026 | Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study |
Q58778301 | Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia |
Q35015398 | Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age |
Q49273753 | Pravastatin for the prevention of adverse pregnancy outcome: preeclampsia and more? |
Q36455584 | Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD). |
Q33416340 | Pre-eclampsia part 1: current understanding of its pathophysiology |
Q38227251 | Pre-eclampsia part 2: prediction, prevention and management |
Q36351625 | Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products |
Q37428029 | Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2. |
Q36670687 | Preeclampsia is associated with low concentrations of protein Z. |
Q37723245 | Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state |
Q34817970 | Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils |
Q61845556 | Pregnancy alters glucose-6-phosphate dehydrogenase trafficking, cell metabolism, and oxidant release of maternal neutrophils |
Q35185510 | Premature labor: a state of platelet activation? |
Q55137301 | Presence of an umbilical artery notch in monochorionic/monoamniotic twins. |
Q34315899 | Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes |
Q34011041 | Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes |
Q26827262 | Progesterone to prevent spontaneous preterm birth |
Q36979414 | Prolactin receptor gene polymorphisms are associated with gestational diabetes |
Q33384672 | Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry |
Q35104787 | Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z. |
Q33993861 | Quantitative T2 changes and susceptibility-weighted magnetic resonance imaging in murine pregnancy |
Q30475932 | Repeatability and reproducibility of fetal cardiac ventricular volume calculations using spatiotemporal image correlation and virtual organ computer-aided analysis |
Q35217350 | Resistin in amniotic fluid and its association with intra-amniotic infection and inflammation |
Q34234671 | Retinol binding protein 4--a novel association with early-onset preeclampsia |
Q36627218 | Retinol binding protein 4: an adipokine associated with intra-amniotic infection/inflammation |
Q36185223 | Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus |
Q34061690 | Screening for congenital hypothyroidism in newborns transferred to neonatal intensive care |
Q43981244 | Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome |
Q36185056 | Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice |
Q36179220 | Single and Serial Fetal Biometry to Detect Preterm and Term Small- and Large-for-Gestational-Age Neonates: A Longitudinal Cohort Study |
Q34281893 | Soluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune response |
Q34164039 | Soluble ST2, a modulator of the inflammatory response, in preterm and term labor |
Q33910907 | Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infection |
Q61845543 | Spontaneous Term Labor Is Associated with Increased Fetal Plasma Concentrations of Interleukin-6 |
Q37726840 | Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes |
Q35214120 | Sterile intra-amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance |
Q42285335 | Strain at the internal cervical os assessed with quasi-static elastography is associated with the risk of spontaneous preterm delivery at ≤34 weeks of gestation |
Q24630219 | Surfactant protein-A as an anti-inflammatory component in the amnion: implications for human pregnancy |
Q57081457 | Term and Preterm Parturition |
Q34150192 | The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia |
Q36984480 | The calcium binding protein, S100B, is increased in the amniotic fluid of women with intra-amniotic infection/inflammation and preterm labor with intact or ruptured membranes |
Q33755648 | The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. |
Q36173859 | The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes |
Q37564500 | The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women |
Q36163743 | The concentration of surfactant protein-A in amniotic fluid decreases in spontaneous human parturition at term |
Q34985972 | The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6. |
Q30436028 | The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis |
Q36165640 | The frequency and clinical significance of intra-amniotic infection and/or inflammation in women with placenta previa and vaginal bleeding: an unexpected observation |
Q35593888 | The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion |
Q36629793 | The maternal HLA-G 1597ΔC null mutation is associated with increased risk of pre-eclampsia and reduced HLA-G expression during pregnancy in African-American women |
Q38436237 | The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study |
Q38505214 | The molecular basis for sonographic cervical shortening at term: identification of differentially expressed genes and the epithelial-mesenchymal transition as a function of cervical length |
Q40230103 | The pattern and magnitude of "in vivo thrombin generation" differ in women with preeclampsia and in those with SGA fetuses without preeclampsia |
Q47645647 | The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). |
Q50102668 | The profiles of soluble adhesion molecules in the "great obstetrical syndromes". |
Q36163599 | The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). |
Q36692485 | The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester |
Q36055381 | The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome |
Q49312791 | The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia |
Q51988193 | The use of the minimum projection mode in 4-dimensional examination of the fetal heart with spatiotemporal image correlation. |
Q33789021 | The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term |
Q40196259 | Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes |
Q24323351 | Tissue factor and its natural inhibitor in pre-eclampsia and SGA |
Q42469778 | Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis |
Q30464228 | Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix |
Q34400892 | Transcriptome interrogation of human myometrium identifies differentially expressed sense-antisense pairs of protein-coding and long non-coding RNA genes in spontaneous labor at term |
Q35231766 | Transcriptomics of maternal and fetal membranes can discriminate between gestational-age matched preterm neonates with and without cognitive impairment diagnosed at 18-24 months |
Q36538942 | Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies |
Q34470845 | Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid |
Q51909063 | Unexplained fetal death: another anti-angiogenic state. |
Q36487287 | Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis |
Q36399720 | Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. |
Q36419240 | Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight |
Q36968586 | Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition |
Q57081285 | [54-OR] |
Q57081286 | [80-OR] |
Q57081288 | [90-OR] |
Q34018925 | miR-143 regulation of prostaglandin-endoperoxidase synthase 2 in the amnion: implications for human parturition at term |
Q35176633 | miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies |
Q38237760 | von Hippel-Lindau disease and pregnancy: what an obstetrician should know |
Search more.